Trial Profile
Clinical Trials Insight: 700012620
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 06 Mar 2006
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Capecitabine; Folitixorin
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Mast Therapeutics
- 06 Mar 2006 New trial record.